Summary of Study ST001023
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000684. The data can be accessed directly via it's Project DOI: 10.21228/M8868G This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST001023 |
Study Title | H3K27M cells and glutamine metabolomics 1 million cell test (part-I) |
Study Summary | Testing TCA concentrations of Diffuse Intrinsic Pontine Gliomas (DIPG) cellines with H3K27M mutations. One million cells are tested with a TCA concentrations panel. We are a high volume center for treating malignant gliomas, which gives us an advantage in obtaining tissue for these relatively rare tumors. We have developed several DIPG patient derived cell lines and xenografts that bear all the key molecular features of this disease including the H3K27M mutation and global H3K27 hypomethylation. These cells are low in passage and we think these lines more closely resemble the patients tumor pathology then established cell lines that have been in culture/mice for numerous years. |
Institute | Mayo Clinic |
Last Name | Daniels |
First Name | David |
Address | 200 First Street SW Rochester, MN 55905 |
daniels.david@mayo.edu | |
Phone | 507-284-2511 |
Submit Date | 2018-07-18 |
Analysis Type Detail | GC-MS |
Release Date | 2020-07-15 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Sample Preparation:
Sampleprep ID: | SP001069 |
Sampleprep Summary: | TCA Concentrations in glioma cell lines |